ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for monitor Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.

AMPH Amphastar Pharmaceuticals Inc

41.11
0.28 (0.69%)
26 Abr 2024 - Cerrado
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Amphastar Pharmaceuticals Inc AMPH NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
0.28 0.69% 41.11 19:00:00
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
40.77 40.50 41.42 41.11 40.83
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
08/3/202415:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/3/202415:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/3/202415:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202417:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202416:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202416:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/3/202419:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/3/202415:06EDGAR2Form 144 - Report of proposed sale of securities
29/2/202415:53EDGAR2Form S-8 - Securities to be offered to employees in employee..
28/2/202415:38EDGAR2Form 8-K - Current report
09/2/202416:21EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
02/2/202418:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/2/202415:03EDGAR2Form 144 - Report of proposed sale of securities
23/1/202410:53EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
11/1/202415:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/1/202417:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/1/202415:25EDGAR2Form 144 - Report of proposed sale of securities
09/1/202415:22EDGAR2Form 144 - Report of proposed sale of securities
08/1/202415:23EDGAR2Form 144 - Report of proposed sale of securities
03/1/202418:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/1/202415:07EDGAR2Form 144 - Report of proposed sale of securities
05/12/202317:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/12/202319:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/12/202315:11EDGAR2Form 144 - Report of proposed sale of securities
17/11/202311:34EDGAR2Form 144 - Report of proposed sale of securities
15/11/202315:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/11/202311:38EDGAR2Form 144 - Report of proposed sale of securities
08/11/202315:24EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/11/202315:14EDGAR2Form 8-K - Current report
02/11/202319:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/11/202315:08EDGAR2Form 144 - Report of proposed sale of securities
03/10/202317:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/10/202315:01EDGAR2Form 144 - Report of proposed sale of securities
15/9/202315:11EDGAR2Form 8-K - Current report
12/9/202311:10DJNAmphastar Pharmaceuticals Shares Down 9% After Private Notes..
29/8/202317:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/8/202315:03EDGAR2Form 144 - Report of proposed sale of securities
16/8/202316:24EDGAR2Form 8-K/A - Current report: [Amend]
08/8/202315:17EDGAR2Form 8-K - Current report
30/6/202315:21EDGAR2Form 8-K - Current report

Su Consulta Reciente

Delayed Upgrade Clock